AeroLeads people directory · profile

Agnes Rafalko Email & Phone Number

Drug Discovery & Non-clinical Development | RNA Therapies, Small Molecules & Biologics | Founder of a Rare Disease Company at Bio Transcript
Location: Killingworth, Connecticut, United States 8 work roles 2 schools
1 work email found @glycomine.com 4 phones found area 415 and 617 LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 4 phones

Work email a****@glycomine.com
Direct phone (415) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Drug Discovery & Non-clinical Development | RNA Therapies, Small Molecules & Biologics | Founder of a Rare Disease Company
Location
Killingworth, Connecticut, United States

Who is Agnes Rafalko? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Agnes Rafalko is listed as Drug Discovery & Non-clinical Development | RNA Therapies, Small Molecules & Biologics | Founder of a Rare Disease Company at Bio Transcript, based in Killingworth, Connecticut, United States. AeroLeads shows a work email signal at glycomine.com, phone signal with area code 415, 617, and a matched LinkedIn profile for Agnes Rafalko.

Agnes Rafalko previously worked as Investment Advisor at Bio Transcript and Director of R&D, Rare Genetic Diseases at Mina Therapeutics. Agnes Rafalko holds Ph.D., Biochemistry And Nanomedicine from Northeastern University.

Company email context

Email format at Bio Transcript

This section adds company-level context without repeating Agnes Rafalko's masked contact details.

{first_initial}{last}@glycomine.com
86% confidence

AeroLeads found 1 current-domain work email signal for Agnes Rafalko. Compare company email patterns before reaching out.

Profile bio

About Agnes Rafalko

Dynamic scientist with 15 years of industry experience in successfully navigating the intricate drug development process to advance therapies for multisystemic hereditary diseases from laboratory research to clinical trials. Skilled in the development and execution of research and IND-enabling strategies for lipid nanoparticle based RNA therapies, small molecules, and biologics. Founder of a clinical stage rare disease company. Experienced in leading early-stage biotech operations, developing strategic plans, building highly efficient teams, and securing venture capital funding. Possesses a deep understanding of both established and emerging biotechnologies, along with their associated challenges and market potential.

Listed skills include Analytical Chemistry, Hplc, Bioinformatics, Protein Chemistry, and 6 others.

Current workplace

Agnes Rafalko's current company

Company context helps verify the profile and gives searchers a useful next step.

Bio Transcript
Bio Transcript
Drug Discovery & Non-clinical Development | RNA Therapies, Small Molecules & Biologics | Founder of a Rare Disease Company
AeroLeads page
8 roles

Agnes Rafalko work experience

A career timeline built from the work history available for this profile.

Investment Advisor

Current

London, Gb

BIO TRANSCRIPT is a venture capital firm investing in therapeutics in the areas of neurology, rare diseases, and gene therapy.

Sep 2021 - Present

Director Of R&D, Rare Genetic Diseases

London, Gb

MiNA develops small activating RNAs as new medicines for cancer and rare genetic diseases.

Dec 2020 - Dec 2022

Managing Director

Popcorn Bio is a life sciences start-up accelerator.

Aug 2019 - Dec 2020

Founder, Chief Executive & Scientific Officer

San Carlos, California, Us

GLYCOMINE develops small molecule replacement therapies for critical unmet orphan diseases of glycosylation (sugar coating of proteins).

Nov 2014 - Oct 2019

Quality Control Analyst

New York, New York, Us

Aug 2004 - Aug 2005
2 education records

Agnes Rafalko education

Ph.D., Biochemistry And Nanomedicine

Northeastern University

B.S., Biology And Chemistry

University Of Saint Joseph
FAQ

Frequently asked questions about Agnes Rafalko

Quick answers generated from the profile data available on this page.

What company does Agnes Rafalko work for?

Agnes Rafalko works for Bio Transcript.

What is Agnes Rafalko's role at Bio Transcript?

Agnes Rafalko is listed as Drug Discovery & Non-clinical Development | RNA Therapies, Small Molecules & Biologics | Founder of a Rare Disease Company at Bio Transcript.

What is Agnes Rafalko's email address?

AeroLeads has found 1 work email signal at @glycomine.com for Agnes Rafalko at Bio Transcript.

What is Agnes Rafalko's phone number?

AeroLeads has found 4 phone signal(s) with area code 415, 617 for Agnes Rafalko at Bio Transcript.

Where is Agnes Rafalko based?

Agnes Rafalko is based in Killingworth, Connecticut, United States while working with Bio Transcript.

What companies has Agnes Rafalko worked for?

Agnes Rafalko has worked for Bio Transcript, Mina Therapeutics, Popcorn Bio, Glycomine Inc., and Biomarin Pharmaceutical Inc..

How can I contact Agnes Rafalko?

You can use AeroLeads to view verified contact signals for Agnes Rafalko at Bio Transcript, including work email, phone, and LinkedIn data when available.

What schools did Agnes Rafalko attend?

Agnes Rafalko holds Ph.D., Biochemistry And Nanomedicine from Northeastern University.

What skills is Agnes Rafalko known for?

Agnes Rafalko is listed with skills including Analytical Chemistry, Hplc, Bioinformatics, Protein Chemistry, Mass Spectrometry, Lc Ms/Ms, Maldi Tof, and Proteomics.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.